![Tracey McCain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tracey McCain
Director/Board Member at
Kiniksa Pharmaceuticals Ltd.
Net worth: 981 313 $ as of 2026-06-29
Profile
Tracey L.
McCain is currently an Independent Director at Kiniksa Pharmaceuticals Ltd. since 2018, an Independent Director at Kiniksa Pharmaceuticals International Plc since 2024, and a Trustee at Dana-Farber Cancer Institute, Inc. Former roles include Independent Director at ImmunoGen, Inc. from 2021 to 2024, Secretary, Chief Legal & Compliance Officer at Blueprint Medicines Corp.
from 2016 to 2025, Senior Vice President & Head-Legal at Genzyme Therapeutics Ltd. in 2016, General Counsel at Genzyme Corp.
from 1997 to 2016, and Associate at Palmer & Dodge LLP.
Education includes an undergraduate degree from the University of Pennsylvania in 1989 and a graduate degree from Columbia Law School in 1992.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.03% | 2026-05-28 | 15,345 ( 0.03% ) | 981 313 $ | 2026-06-29 |
Tracey McCain active positions
| Companies | Position | Start |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Director/Board Member | 2018-01-31 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Director/Board Member | - |
Former positions of Tracey McCain
| Companies | Position | End |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 2025-09-30 |
| IMMUNOGEN, INC. | Director/Board Member | 2024-02-11 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | General Counsel | 2016-09-01 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 2016-08-31 |
Palmer & Dodge LLP
 Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Training of Tracey McCain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palmer & Dodge LLP
Palmer & Dodge LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Tracey McCain
Choose MarketScreener 
